The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 63.20
Ask: 66.00
Change: -1.00 (-1.54%)
Spread: 2.80 (4.43%)
Open: 64.60
High: 66.00
Low: 64.00
Prev. Close: 65.00
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings & Holdings in Company

17 Jan 2020 12:12

RNS Number : 1994A
IDOX PLC
17 January 2020
 

Idox Plc

 

Directors' Dealings & Holdings in Company

Idox plc (LSE:IDOX, "Company" or "Idox") received notification on 15 January 2020 from Kestrel Partners LLP ("Kestrel") that on 14 January 2020 it transferred, on behalf of a discretionary client, 105,720 ordinary shares of 1p each ("Shares") in the Company from accounts managed by Kestrel to the client's broker accounts. This transfer by Kestrel was made at the request of the client and there is no change in ultimate beneficial ownership. The notification also included the matters set out below.

Mr Scott, a non-executive director of Idox, is a partner of, and holds a beneficial interest in Kestrel. Mr Scott is also a shareholder in one of Kestrel's clients ("Kestrel Opportunities") and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Idox.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 33,537,916 shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest hold 12,338,642 Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 45,876,558 shares in the Company, which represents 10.35% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

33,537,916

7.57%

Indirect

JIM Nominees Limited

2,351,509

0.53%

Indirect

Bank of New York Nominees Ltd

9,752,823

2.20%

Indirect

Bank of New York Nominees Ltd

234,310

0.05%

 

For further information contact:

 

Idox plc +44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive

Rob Grubb, Chief Financial Officer

 

N+1 Singer (NOMAD and Broker) +44 (0) 20 7496 3000

Shaun Dobson / Ben Farrow (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP ('Kestrel')

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Rupert Andrew Scott (non-executive director of Idox plc and Partner in Kestrel)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

IDOX Plc

b)

 

LEI

 

 

213800Z3FE6PWVSUGE70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

1p Ordinary Shares

 

 

 

ISIN: GB0002998192

 

b)

 

Nature of the transaction

 

 

Transfer for a client account managed by Kestrel to client account held at separate broker. No change of beneficial ownership.

c)

 

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

N/A

 

105,720 Shares

 

 

 

 

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Transfer of 105,720 shares at zero cost.

 

 

e)

 

Date of the transaction

 

2020-01-14

f)

 

Place of the transaction

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEAAFXFFFEEFA
Date   Source Headline
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company
30th Aug 20198:18 amRNSHolding(s) in Company
30th Aug 20198:16 amRNSHolding(s) in Company
30th Aug 20197:00 amRNSDirectors' Dealings & Holdings in Company
20th Aug 20199:20 amRNSHolding(s) in Company
9th Aug 20193:16 pmRNSCompletion of Acquisition of Tascomi Ltd
8th Aug 201910:56 amRNSHolding(s) in Company
6th Aug 20198:06 amRNSDirectors' Dealings & Holdings in Company
31st Jul 201910:30 amRNSFurther Details on the Fundraising
31st Jul 20197:00 amRNSProposed Fundraising via accelerated bookbuild
22nd Jul 20197:00 amRNSHalf-year Report
4th Apr 20194:17 pmRNSDirector/PDMR Share Dealing
3rd Apr 20197:00 amRNSBoard Change
29th Mar 20191:08 pmRNSResult of AGM
29th Mar 20197:00 amRNSAGM Trading Update & 2016 Prior Year Adjustment
22nd Mar 20197:00 amRNSDirectorate Change
18th Mar 20195:16 pmRNSOption Awards
12th Mar 20193:17 pmRNSDirector Dealings and Option Awards
7th Mar 20191:29 pmRNSPosting of Annual Report and Notice of AGM
21st Feb 20197:00 amRNSFinal Results for the year ended 31 October 2018
20th Feb 20192:13 pmRNSExercise of Share Options & Total Voting Rights
1st Feb 20198:20 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSExtension of Banking Facilities
22nd Jan 20198:24 amRNSHolding(s) in Company
7th Jan 20192:50 pmRNSBoard Change
27th Nov 20187:00 amRNSYear End Trading Update
22nd Nov 20187:00 amRNSDirectorate Change
19th Nov 20187:00 amRNSDirectorate Change
5th Nov 20187:00 amRNSDisposal of Digital division
31st Oct 20187:00 amRNSDirectorate Change
25th Oct 20183:23 pmRNSHolding(s) in Company
19th Oct 20185:01 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSAppointment of Chief Financial Officer
12th Sep 20183:46 pmRNSHolding(s) in Company
10th Sep 201811:22 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.